Current Status of Asthma Care in South Korea: Nationwide the Health Insurance Review and Assessment Service Database

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2017 Dec 10

PMID 29221297

Citations 31

Authors

Joon Young Choi

Hyoung Kyu Yoon

Jae Ha Lee

Kwang Ha Yoo

Bo Yeon Kim

Hye Won Bae

Young Kyoon Kim

Chin Kook Rhee

Affiliations

Soon will be listed here.

Abstract

Background: Quality control is important for patients with asthma because of its prevalence and because the social burden is substantial. This study analyzed the Health Insurance Review and Assessment Service (HIRA) database to assess asthma quality control in South Korea.

Methods: We investigated the HIRA nationwide database for reimbursed insurance claims from all medical institutions in South Korea from July 2013 to June 2014. The number of patients with asthma were evaluated and the medical institutions were categorized by type of medical institution. Asthma care quality was assessed by measuring the performance rate on pulmonary function test (PFT) and investigating prescriptions for asthma medications.

Results: A total of 16,804 medical institutions and 831,613 patients were included in this study. Among them, primary health clinics accounted for 87.75% of all medical institutions and 82.50% of patients were treated in a primary health clinic. The overall PFT performance rate was 23.47%, which was highest in tertiary hospitals (80.59%) and relatively lower in primary health clinics (17.06%). Oral agents were prescribed to 93.96% of patients, whereas inhaled agents were prescribed to only 30.34%. Oral corticosteroids were prescribed to 40.61% of patients, leukotriene antagonists to 48.78%, and inhaled corticosteroids (ICS) to 25.37% of patients by drug category.

Conclusions: Most patients with asthma were treated in primary health clinics rather than higher class medical institutions. Asthma quality control was poor regarding usage of diagnostic measures and prescribed medications.

Citing Articles

COVID-19 and risk of long-term mortality in COPD: a nationwide population-based cohort study.

Lee H, Kim S, Jeong C, Chung J, Kim Y, Min K BMJ Open Respir Res. 2025; 12(1).

PMID: 39961706 PMC: 11836811. DOI: 10.1136/bmjresp-2024-002694.

Effect of add-on therapy with leukotriene receptor antagonists and Chungsangboha-tang in patients with asthma: a protocol for a randomized, placebo-controlled, parallel, multicenter trial.

Kang S, Nam H, Park Y, Choi J, Kim K, Ha S BMC Complement Med Ther. 2025; 25(1):54.

PMID: 39953492 PMC: 11829457. DOI: 10.1186/s12906-025-04799-w.

Appropriate Allergic Rhinitis Medications Can Reduce Systemic Steroid Requirement and Prevent Rhinosinusitis.

Byun M, Yang W, Choi Y, Kim C, Cho J, Kim H J Clin Med. 2024; 13(22).

PMID: 39597953 PMC: 11595140. DOI: 10.3390/jcm13226809.

Analysis of olfactory function in patients with chronic rhinosinusitis and Staphylococcus aureus enterotoxin positivity.

Kim M, Chae H, Kwon D, Jeon E, Lee Y, Lee E Sci Rep. 2024; 14(1):26138.

PMID: 39478131 PMC: 11525943. DOI: 10.1038/s41598-024-77459-7.

Prescription patterns and effectiveness of medications for chronic obstructive pulmonary disease: A retrospective study of real-world settings.

Park H, Lee J, Jeon S, Lee H, Kim B, Chae Y PLoS One. 2024; 19(6):e0304362.

PMID: 38857214 PMC: 11164367. DOI: 10.1371/journal.pone.0304362.

References

Fuhlbrigge A, Adams R, Guilbert T, Grant E, Lozano P, Janson S . The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med. 2002; 166(8):1044-9. DOI: 10.1164/rccm.2107057. View

Lai C, DE Guia T, Kim Y, Kuo S, Mukhopadhyay A, Soriano J . Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol. 2003; 111(2):263-8. DOI: 10.1067/mai.2003.30. View

Gibson O, Segal L, McDermott R . A systematic review of evidence on the association between hospitalisation for chronic disease related ambulatory care sensitive conditions and primary health care resourcing. BMC Health Serv Res. 2013; 13:336. PMC: 3765736. DOI: 10.1186/1472-6963-13-336. View

Kay A . Allergy and allergic diseases. First of two parts. N Engl J Med. 2001; 344(1):30-7. DOI: 10.1056/NEJM200101043440106. View

Gershon A, Victor J, Guan J, Aaron S, To T . Pulmonary function testing in the diagnosis of asthma: a population study. Chest. 2011; 141(5):1190-1196. DOI: 10.1378/chest.11-0831. View

Anandan C, Nurmatov U, van Schayck O, Sheikh A . Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2009; 65(2):152-67. DOI: 10.1111/j.1398-9995.2009.02244.x. View

Sullivan P, Slejko J, Ghushchyan V, Sucher B, Globe D, Lin S . The relationship between asthma, asthma control and economic outcomes in the United States. J Asthma. 2014; 51(7):769-78. DOI: 10.3109/02770903.2014.906607. View

Williams S, Wagner S, Kannan H, Bolge S . The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med. 2009; 51(7):780-5. DOI: 10.1097/JOM.0b013e3181abb019. View

Steppuhn H, Langen U, Mueters S, Dahm S, Knopf H, Keil T . Asthma management practices in adults--findings from the German Health Update (GEDA) 2010 and the German National Health Interview and Examination Survey (DEGS1) 2008-2011. J Asthma. 2015; 53(1):50-61. DOI: 10.3109/02770903.2015.1059853. View

10.

Sullivan P, Ghushchyan V, Slejko J, Belozeroff V, Globe D, Lin S . The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2011; 127(2):363-369.e1-3. DOI: 10.1016/j.jaci.2010.10.042. View

11.

Masoli M, Fabian D, Holt S, Beasley R . The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004; 59(5):469-78. DOI: 10.1111/j.1398-9995.2004.00526.x. View

12.

To T, Guan J, Zhu J, Lougheed M, Kaplan A, Tamari I . Quality of asthma care under different primary care models in Canada: a population-based study. BMC Fam Pract. 2015; 16:19. PMC: 4336688. DOI: 10.1186/s12875-015-0232-y. View

13.

Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D . Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study. Respir Res. 2016; 17(1):51. PMC: 4894377. DOI: 10.1186/s12931-016-0374-z. View

14.

Haahtela T, Tuomisto L, Pietinalho A, Klaukka T, Erhola M, Kaila M . A 10 year asthma programme in Finland: major change for the better. Thorax. 2006; 61(8):663-70. PMC: 2104683. DOI: 10.1136/thx.2005.055699. View

15.

Weidinger P, Nilsson J, Lindblad U . Adherence to diagnostic guidelines and quality indicators in asthma and COPD in Swedish primary care. Pharmacoepidemiol Drug Saf. 2009; 18(5):393-400. DOI: 10.1002/pds.1734. View

16.

Kim D, Park Y, Oh Y, Jung K, Yoo J, Yoo K . Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014. Tuberc Respir Dis (Seoul). 2016; 79(3):111-20. PMC: 4943894. DOI: 10.4046/trd.2016.79.3.111. View